Related Experiment Videos
Neuropeptide-processing enzymes: applications for drug discovery.
1Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. fricker@aecom.yu.edu
The AAPS Journal
|December 16, 2005
Summary
Neuropeptides are key for cell communication and drug discovery. While inhibiting processing enzymes is challenging, studying enzyme-deficient animals reveals new neuropeptide targets for therapies.
Area of Science:
- Biochemistry
- Neuroscience
- Pharmacology
Background:
- Neuropeptides are vital signaling molecules involved in intercellular communication.
- Their synthesis involves selective enzymatic cleavage of precursor proteins, followed by degradation.
- Peptidases play a crucial role in both neuropeptide biosynthesis and breakdown.
Purpose of the Study:
- To explore the therapeutic potential of targeting neuropeptide processing.
- To understand the consequences of inhibiting peptide-processing enzymes.
- To identify novel neuropeptide targets through studies of enzyme-deficient models.
Main Methods:
- Analysis of neuropeptide biosynthesis and degradation pathways.
- Investigation of the effects of inhibiting key peptidases.
- Utilizing mutant animal models lacking functional peptide-processing enzymes.
Main Results:
- A small number of peptidases process numerous neuropeptides, complicating direct enzyme inhibition as a therapeutic strategy.
- Inhibition of a single enzyme broadly affects multiple neuropeptides, reducing therapeutic specificity.
- Studies in mutant animals have successfully identified novel neuropeptides.
Conclusions:
- Direct inhibition of common neuropeptide-processing enzymes is unlikely to yield effective therapeutics due to broad effects.
- Mutant animal studies offer a valuable approach for discovering novel neuropeptides.
- These newly discovered neuropeptides represent promising targets for future therapeutic development.